CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-20 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Options (right to buy) | +2,580 | 2,580 | ||
| 2025-05-15 | Soergel David Chief Medical Officer | Grant or award | +7,545 | 7,545 | ||
| 2025-05-15 | Soergel David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +12,839 | 12,839 | ||
| 2025-04-10 | Levy Richard S Director | Option exercise | +9,470 | $65.06 | $616K | 20,482 |
| 2025-04-10 | Levy Richard S Director | Option exercise · Stock Option (Right to Buy) | −9,470 | 0 | ||
| 2025-03-13 | CRAVES FRED B Director | Option exercise | +7,742 | $65.06 | $504K | 357,818 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −1,951 | $322.45 | $629K | 355,867 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −1,649 | $323.47 | $533K | 354,218 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −900 | $324.69 | $292K | 353,318 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −800 | $325.63 | $261K | 352,518 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −1,000 | $327.63 | $328K | 351,518 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −400 | $328.68 | $131K | 351,118 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −967 | $329.86 | $319K | 350,151 |
| 2025-03-13 | CRAVES FRED B Director | Sale | −75 | $330.23 | $25K | 350,076 |
| 2025-03-13 | CRAVES FRED B Director | Option exercise · Stock Option (Right to Buy) | −7,742 | 0 | ||
| 2025-03-12 | CRAVES FRED B Director | Option exercise | +1,728 | $65.06 | $112K | 351,804 |
| 2025-03-12 | CRAVES FRED B Director | Option exercise | +6,000 | $111.06 | $666K | 357,804 |
| 2025-03-12 | CRAVES FRED B Director | Sale | −1,587 | $330.54 | $525K | 356,217 |
| 2025-03-12 | CRAVES FRED B Director | Sale | −2,759 | $331.36 | $914K | 353,458 |
| 2025-03-12 | CRAVES FRED B Director | Sale | −2,382 | $332.38 | $792K | 351,076 |
Page 23 of 82 · 1,629 trades